Forecast & Rating4 analysts currently cover ARS Pharmaceuticals, of which 4 give a positive rating. The average price target is $23.25, about 272.6% upside from the current price of $6.24. Coverage is limited, so the data is for reference only. Data as of Aug 15, 2026; this does not constitute investment advice.
Aug 14, 2026Price forecast
$23.25272.60%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met25.0%
Stock price$6.24
Avg. target$23.3
High target$30
Low target$17
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.